大鼠背根神经节磷酸化蛋白质组学揭示mTOR是骨癌痛及电针镇痛的潜在靶点
该研究通过磷酸化蛋白质组学分析骨癌痛大鼠背根神经节,发现mTOR信号通路显著富集,mTOR Ser2448和Thr2446磷酸化在骨癌痛中升高且被电针下调,抑制mTOR可缓解痛敏而mTOR激动剂削弱电针镇痛效果,提示mTOR信号是电针缓解骨癌痛的潜在靶点。
要点
- 骨癌痛大鼠背根神经节中mTOR信号通路磷酸化蛋白显著富集。
- 电针可下调骨癌痛引起的mTOR Ser2448和Thr2446磷酸化升高。
- 抑制mTOR缓解骨癌痛痛敏,mTOR激动剂削弱电针镇痛效应。
核心结论
- mTOR信号通路在骨癌痛大鼠背根神经节中被激活,电针部分通过下调mTOR信号发挥镇痛作用。
- mTOR信号可作为电针缓解骨癌痛的潜在治疗靶点。
研究设计与样本
- 研究采用胫骨接种MRMT-1乳腺癌细胞建立骨癌痛大鼠模型,以机械痛阈和影像学骨破坏确认建模成功。
- 通过PEX100蛋白微阵列分析骨癌痛建模与电针治疗共同调控的背根神经节差异磷酸化蛋白,并行KEGG通路富集分析。
主要发现
- 骨癌痛大鼠机械痛阈降低且影像学显示骨破坏,电针治疗可减轻上述表现。
- KEGG分析显示差异磷酸化蛋白显著富集于mTOR信号通路。
- 骨癌痛中mTOR Ser2448和Thr2446磷酸化升高,电针下调其磷酸化。
- mTOR复合物标志物S6K和Akt磷酸化在骨癌痛中升高,电针下调其磷酸化。
- 抑制mTOR信号缓解骨癌痛大鼠痛阈,mTOR激动剂削弱电针镇痛效果。
临床怎么用
- 电针可作为骨癌痛的部分镇痛手段,其效应可能与下调背根神经节mTOR信号相关。
- mTOR信号状态可能影响电针镇痛效果,抑制mTOR或可增强电针在骨癌痛中的镇痛作用。
局限性
- 研究为大鼠骨癌痛模型,结论外推至临床需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bone cancer pain (BCP) is a clinical refractory mixed pain involving neuropathic and inflammatory pain, with the underlying mechanisms remaining largely unknown. Electro-acupuncture (EA) can partly alleviate BCP according to previous research. We aim to explore the proteins and major pathways involved in BCP and EA treatment through phosphoproteomic profiling. BCP rat model was built by tibial inoculation of MRMT-1 mammary gland carcinoma cells. Mechanical hyperalgesia determined by paw withdrawal thresholds (PWTs) and bone destruction manifested on the radiographs confirmed the success of modeling, which were attenuated by EA treatment. The differentially expressed phosphorylated proteins (DEPs) co-regulated by BCP modeling and EA treatment in rat dorsal root ganglions (DRGs) were analyzed through PEX100 Protein microarray. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis revealed that DEPs were significantly enriched in mammalian target of rapamycin (mTOR) signaling pathway. The phosphorylations of mTOR at Ser2448 and Thr2446 were increased in BCP and downregulated by EA. In addition, the phosphorylation of S6K and Akt, markers of the mTOR complex, were also increased in BCP and downregulated by EA. Inhibition of mTOR signaling alleviated the PWTs of BCP rats, while the mTOR agonist impaired the analgesic effect of EA. Thus, our study provided a landscape of protein phosphorylation changes in DRGs of EA-treated BCP rats and revealed that mTOR signaling can be potentially targeted to alleviate BCP by EA treatment.
引用
- Wang W, Zhou Y, Cai Y, et al. Phosphoproteomic Profiling of Rat's Dorsal Root Ganglia Reveals mTOR as a Potential Target in Bone Cancer Pain and Electro-Acupuncture's Analgesia. Front Pharmacol. 2021. PMID: 33995007. doi:10.3389/fphar.2021.593043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。